4.6 Article

APOBEC3B and APOBEC3C are potent inhibitors of simian immunodeficiency virus replication

Journal

JOURNAL OF BIOLOGICAL CHEMISTRY
Volume 279, Issue 51, Pages 53379-53386

Publisher

AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
DOI: 10.1074/jbc.M408802200

Keywords

-

Funding

  1. NIAID NIH HHS [AI49131, AI58864] Funding Source: Medline
  2. NIDA NIH HHS [DA14494] Funding Source: Medline

Ask authors/readers for more resources

In the human genome the apolipoprotein B mRNA-editing enzyme catalytic polypeptide ( APOBEC) 3 gene has expanded into a tandem array of genes termed APOBEC3A-G. Two members of this family, APOBEC3G and APOBEC3F, have been found to have potent activity against virion infectivity factor deficient (Deltavif) human immunodeficiency virus 1 (HIV-1). These enzymes become encapsidated in Deltavif HIV-1 virions and in the next round of infection deaminate the newly synthesized reverse transcripts. The lentiviral Vif protein prevents the deamination by inducing the degradation of APOBEC3G and APOBEC3F. We report here that two additional APOBEC3 family members, APOBEC3B and APOBEC3C, have potent antiviral activity against simian immunodeficiency virus (SIV), but not HIV-1. Both enzymes were encapsidated in HIV-1 and SIV virions and were active against Deltavif SIVmac and SIVagm. SIV Vif neutralized the antiviral activity of APOBEC3C, but not that of APOBEC3B. APOBEC3B induced abundant G --> A mutations in both wild-type and Deltavif SIV reverse transcripts. APOBEC3C induced substantially fewer mutations. APOBEC3F was found to be active against SIV and sensitive to SIVmac Vif. These findings raise the possibility that the different APOBEC3 family members function to neutralize specific lentiviruses.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available